Eagle's Eye View: Your Weekly CV Update From ACC.org

In this week's View, Dr. Eagle looks at predictors of high-grade atrioventricular block (AV) after transcatheter tricuspid valve replacement (TTVR). He then discusses the challenges and benefits of deep learning in automating cardiac imaging (IMG). Finally, Dr. Eagle explores higher survival benefits after the 2018 U.S. Heart Transplantation Allocation policy change. Subscribe to Eagle's Eye View

Delve into the surprising effects of ischemic preconditioning in noncardiac surgeries and its limited benefits. Discover how microaxial flow pumps enhance treatment for STEMI patients in cardiogenic shock, offering crucial hemodynamic support. Plus, explore the intriguing idea of starting direct oral anticoagulants right after a stroke, possibly reducing future stroke risks and complications. This insightful discussion shines a light on innovative strategies in cardiovascular care.

This episode dives into frailty status and its alarming link to increased mortality during percutaneous coronary intervention. Delays in treating STEMI patients are explored, revealing how timing can significantly impact recovery. The discussion also sheds light on genetic factors influencing arterial events in conditions like heritable thoracic aortic disease and Loeys-Dietz Syndrome. These insights highlight the importance of swift treatment and genetic awareness in managing cardiovascular health.

Discover the latest advancements in cardiac procedures, including the lower risk of major adverse events with the new Watchman 2.4 device for left atrial appendage occlusion. Learn about the intriguing dynamics of heart failure care in private equity hospitals and how these settings are reshaping treatment. Plus, delve into the long-term outcomes for patients with tricuspid regurgitation undergoing mitral valve-in-valve replacements, revealing important prognostic insights.

This week, the discussion dives into how chronic marijuana use impairs endothelial function. The hosts compare the bleeding risks and effectiveness of aspirin versus clopidogrel in treating acute coronary syndromes. Additionally, they highlight the often-overlooked mental health challenges faced by survivors of sudden cardiac arrest, particularly those dealing with the aftermath of ICD shocks. The need for comprehensive mental health support in these cases is emphasized.

This week, the discussion focuses on the CATHEDRAL-HF Trial, highlighting carvedilol's role in treating heart failure with improved ejection fraction. The impact of modifiable lifestyle factors on reducing cardiac conduction disease risk is also examined. Lastly, there's a comparison of amiloride and spironolactone for resistant hypertension, showcasing that both drugs lower systolic pressure, but amiloride may be better tolerated by certain patients. Tune in for insights on enhancing cardiac health!

Delve into the fascinating role of colchicine in reducing serious cardiovascular events, like heart attacks, in patients with vascular disease. Discover the latest findings comparing direct oral anticoagulants to warfarin for those recovering from TAVR procedures. Finally, explore the advantages of conduction system pacing over traditional biventricular pacing for improving heart function and echocardiographic responses. Tune in for these invaluable insights into cardiovascular care!

Discover the intriguing results of the ORBITA-2 Trial and its implications for stress echocardiography before PCI. Delve into why some patients struggle to achieve blood pressure control despite escalating their medication. Finally, learn about the promising strategies for rapid initiation and titration of guideline-recommended therapies in those grappling with heart failure and reduced ejection fraction. Each topic sheds light on evolving practices and their impact on patient care.

Delve into the intriguing relationship between Lp(a) levels and cardiovascular risk. Uncover how high-sensitivity C-reactive protein can identify high-risk plaques after NSTEMI. Explore the battle between pulsed field ablation and cryoablation in treating paroxysmal AFib. Each topic reveals cutting-edge insights in cardiovascular health, backed by extensive research and clinical trials.

Discover how weight management during pregnancy can impact cardiovascular disease risk. Learn about the promising effects of adding ezetimibe to statin therapy post-myocardial infarction. Explore the five-year results of the pivotal PARTNER-3 study, comparing outcomes between transcatheter and surgical aortic valve replacements. These insights reveal crucial connections between pregnancy, heart health, and innovative treatment strategies.